Spectromicroscopy of boron for the optimization of boron neutron capture therapy (BNCT) for cancer

Academic Article


  • We used synchrotron spectromicroscopy to study the microscopic distribution of boron in rat brain tumour and healthy tissue in the field of boron neutron capture therapy (BNCT). The success of this experimental cancer therapy depends on the preferential uptake of 10B in tumour cells after injection of a boron compound (in our case B12H11SH, or BSH). With the Mephisto (microscope √† emission de photo√©lectrons par illumination synchrotronique de type onduleur) spectromicroscope, high-magnification imaging and chemical analysis was performed on brain tissue sections from a rat carrying an implanted brain tumour and the results were compared with inductively coupled plasma-atomic emission spectroscopy (ICP-AES) detection of boron in bulk tissue. Boron was found to have been taken up more favourably by regions of tumour rather than healthy tissue, but the resulting boron distribution in the tumour was inhomogeneous. The results demonstrate that Mephisto can perform microchemical analysis of tissue sections, detect and localize the presence of boron with submicron spatial resolution. The application of this technique to boron in brain tissue can therefore be used to evaluate the current efforts to optimize BNC therapy.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Gilbert B; Redondo J; Baudat PA; Lorusso GF; Andres R; Van Meir EG; Brunet JF; Hamou MF; Suda T; Mercanti D
  • Start Page

  • 2642
  • End Page

  • 2647
  • Volume

  • 31
  • Issue

  • 19